about
Valproate in the treatment of epilepsy in girls and women of childbearing potentialPrimary Mitochondrial Disease and Secondary Mitochondrial Dysfunction: Importance of Distinction for Diagnosis and TreatmentTreatments for biomedical abnormalities associated with autism spectrum disorder.Mitochonic Acid 5 (MA-5) Facilitates ATP Synthase Oligomerization and Cell Survival in Various Mitochondrial Diseases.Autism and intellectual disability associated with mitochondrial disease and hyperlactacidemia.Urinary ATP Synthase Subunit β Is a Novel Biomarker of Renal Mitochondrial Dysfunction in Acute Kidney Injury.Potential compounds for the treatment of mitochondrial disease.Evidence for Detrimental Cross Interactions between Reactive Oxygen and Nitrogen Species in Leber's Hereditary Optic Neuropathy Cells.Riboflavin Has Neuroprotective Potential: Focus on Parkinson's Disease and Migraine.Pharmacologic modeling of primary mitochondrial respiratory chain dysfunction in zebrafish.Liver transplantation for pediatric inherited metabolic disorders: Considerations for indications, complications, and perioperative management.Mitochondrial disease patients' perception of dietary supplements' use.Anticonvulsant Medications in Mitochondrial Disease.Therapies for mitochondrial diseases and current clinical trials.Clinical effects of chemical exposures on mitochondrial function.Alpers-Huttenlocher Syndrome First Presented with Hepatic Failure: Can Liver Transplantation Be Considered as Treatment Option?Lesional perfusion abnormalities in Leigh disease demonstrated by arterial spin labeling correlate with disease activity.
P2860
Q26865670-78602462-1A37-499B-A844-18E088CC1F4EQ28078384-6FC394D8-4DAE-4E38-B847-EA3370F1966EQ33814205-FA687203-D3ED-4896-95E0-A81C5EA350AFQ33817804-C183A67A-315C-4F21-A4D1-DB1D878731C3Q35139145-5082A53E-8911-4F55-99E4-176F844E89BBQ35535441-A7FE72F2-13B7-4C1F-98B5-20D70C8260FAQ35847813-85A2A9F9-2DDD-4AA6-A34F-D615DF347347Q36529768-DB45F4EA-C196-4242-B77D-D1E596B295EFQ38647109-9BF59204-B38E-443B-BFD6-5419F2F44270Q38653585-7B8408E2-EB6B-4BEF-85CF-D676C77CC30BQ38872573-0BDEF150-2ABA-4DCF-8CC8-1F7695273733Q39573813-26542D65-6B9D-402B-9C94-7A0B4DBADF23Q45833879-8D299240-1D90-4FF8-B338-90B40198BD68Q45872396-7655199D-3386-48F7-B4D0-1B56BCDBD53EQ46328664-F8892B41-92D2-4045-B2F4-6B47D45B155DQ50183417-79EB2D00-5F70-462A-8455-D27E3B0BACE0Q51535245-629D846B-0F79-4C55-97D3-82D904CEA013
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Treatment of mitochondrial disorders.
@ast
Treatment of mitochondrial disorders.
@en
type
label
Treatment of mitochondrial disorders.
@ast
Treatment of mitochondrial disorders.
@en
prefLabel
Treatment of mitochondrial disorders.
@ast
Treatment of mitochondrial disorders.
@en
P2093
P2860
P1476
Treatment of mitochondrial disorders
@en
P2093
Andrea Gropman
Scott Demarest
Sreenivas Avula
Sumit Parikh
P2860
P2888
P356
10.1007/S11940-014-0292-7
P577
2014-06-01T00:00:00Z